These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 21989184)
1. Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma. Colley HE; Hearnden V; Jones AV; Weinreb PH; Violette SM; Macneil S; Thornhill MH; Murdoch C Br J Cancer; 2011 Nov; 105(10):1582-92. PubMed ID: 21989184 [TBL] [Abstract][Full Text] [Related]
2. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma. Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis. Nitta T; Sugihara K; Tsuyama S; Murata F Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953 [TBL] [Abstract][Full Text] [Related]
4. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia. AbdulMajeed AA; Dalley AJ; Farah CS Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910 [TBL] [Abstract][Full Text] [Related]
5. Organotypic culture of normal, dysplastic and squamous cell carcinoma-derived oral cell lines reveals loss of spatial regulation of CD44 and p75 NTR in malignancy. Dalley AJ; AbdulMajeed AA; Upton Z; Farah CS J Oral Pathol Med; 2013 Jan; 42(1):37-46. PubMed ID: 22643025 [TBL] [Abstract][Full Text] [Related]
6. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance. Öhman J; Magnusson B; Telemo E; Jontell M; Hasséus B Scand J Immunol; 2012 Jul; 76(1):39-48. PubMed ID: 22469080 [TBL] [Abstract][Full Text] [Related]
7. 3D printed tissue engineered model for bone invasion of oral cancer. Almela T; Al-Sahaf S; Brook IM; Khoshroo K; Rasoulianboroujeni M; Fahimipour F; Tahriri M; Dashtimoghadam E; Bolt R; Tayebi L; Moharamzadeh K Tissue Cell; 2018 Jun; 52():71-77. PubMed ID: 29857831 [TBL] [Abstract][Full Text] [Related]
8. Differential immunohistochemical expression profiles of perlecan-binding growth factors in epithelial dysplasia, carcinoma in situ, and squamous cell carcinoma of the oral mucosa. Hasegawa M; Cheng J; Maruyama S; Yamazaki M; Abé T; Babkair H; Saito C; Saku T Pathol Res Pract; 2016 May; 212(5):426-36. PubMed ID: 26965914 [TBL] [Abstract][Full Text] [Related]
9. [Centrosome hyperamplificationin oral precancerous lesions and squamous cell carcinomas]. Cai Y; Li BQ; Cheng QM Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Jun; 22(3):238-41. PubMed ID: 15293475 [TBL] [Abstract][Full Text] [Related]
10. A comparative analysis of langerhans cell in oral epithelial dysplasia and oral squamous cell carcinoma using antibody CD-1a. Upadhyay J; Rao NN; Upadhyay RB J Cancer Res Ther; 2012; 8(4):591-7. PubMed ID: 23361280 [TBL] [Abstract][Full Text] [Related]
11. Comparison of myofibroblasts expression in oral squamous cell carcinoma, verrucous carcinoma, high risk epithelial dysplasia, low risk epithelial dysplasia and normal oral mucosa. Chaudhary M; Gadbail AR; Vidhale G; Mankar Gadbail MP; Gondivkar SM; Gawande M; Patil S Head Neck Pathol; 2012 Sep; 6(3):305-13. PubMed ID: 22392407 [TBL] [Abstract][Full Text] [Related]
12. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis. Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772 [TBL] [Abstract][Full Text] [Related]
13. Characteristics of benign lymphoadenosis of oral mucosa. Li SX; Yu SF; Sun KH World J Gastroenterol; 2005 Aug; 11(29):4536-40. PubMed ID: 16052684 [TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical study of benign lymphoadenosis of oral mucosa]. Li SX; Yu SF; Sun KH Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Sep; 39(5):410-3. PubMed ID: 15498351 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of a fluorescence visualization system for the detection of oral precancerous and early cancerous lesions. Ohnishi Y; Fujii T; Ugaki Y; Yasui H; Watanabe M; Dateoka S; Kakudo K Oncol Rep; 2016 Jul; 36(1):514-20. PubMed ID: 27121913 [TBL] [Abstract][Full Text] [Related]
16. Expression of p16 in oral cancer and premalignant lesions. Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055 [TBL] [Abstract][Full Text] [Related]
17. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis. Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma. Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma. Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745 [No Abstract] [Full Text] [Related]
20. The expression of laminin-5 in severe dysplasia/carcinoma in situ and early invasive squamous cell carcinoma: an immunohistochemical study. Rahman F; Rao NN; Tippu SR; Patil S; Agarwal S; Srivastava S Minerva Stomatol; 2013 May; 62(5):139-46. PubMed ID: 23715200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]